GCTK (GlucoTrack, Inc. Common Stock) Stock Analysis - AI Report

GlucoTrack, Inc. Common Stock (GCTK) is a publicly traded Healthcare sector company. As of May 21, 2026, GCTK trades at $0.47 with a market cap of $1.77M and a P/E ratio of 0.01. GCTK moved -13.39% today. Year to date, GCTK is -87.99%; over the trailing twelve months it is -94.71%. Its 52-week range spans $0.44 to $2,970.00. Rallies surfaces GCTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on GCTK?

Rallies AI research for GCTK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

GCTK Key Metrics

Key financial metrics for GCTK
MetricValue
Price$0.47
Market Cap$1.77M
P/E Ratio0.01
EPS$31.22
Dividend Yield0.00%
52-Week High$2,970.00
52-Week Low$0.44
Volume21.87K
Avg Volume0
Revenue (TTM)$0
Net Income$-19.39M
Gross Margin0.00%

Latest GCTK News

Recent GCTK Insider Trades

  • SYCOFF DREW bought 182.54K (~$230.00K) on Apr 22, 2024.

GCTK Analyst Consensus

GCTK analyst coverage data. Average price target: $0.00.

Common questions about GCTK

What is the AI research view on GCTK?
Rallies AI research for GCTK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for GCTK?
Rallies AI research for GCTK combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is GCTK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GCTK. It does not provide personalized investment advice.
GCTK

GCTK